Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastomaReza Bayat Mokhtari(European Automobile Manufacturers Association), Herman Yeger(University of Toronto)BMC CancerFebruary 24, 201710.1186/s12885-017-3126-7Cited by 46SaveCiteExport RISWatch citationsRelated PapersHypoxia Enhances Tumor Stemness by Increasing the Invasive and Tumorigenic Side Population Fraction|Stem Cells|2008|305Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis|Oncotarget|2021|23Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane|BMC Cancer|2019|17